The Efficacy of Kinesio Taping With Therapy in the Treatment of Globus Pharyngeus

The Efficacy of Kinesio Taping With Therapy in the Treatment of Globus Pharyngeus: a Randomized Sham-controlled Trial

Globus pharyngeus or sensation may be defined as a feeling of something a lump in the throat without dysphagia. Kinesio tex tape is a medical tap developed by Dr. Kase for therapeutic purposes and has been widely used in physical therapy applications in recent years. Although it is not a treatment with full consensus, the patient's complaints can be corrected with a small number of different therapy techniques or regulations on life.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

We conducted a therapy program with kinesio taping on patients who diagnosed with globus pharyngeus for 8 session with sham kinesio taping controlled group. This study aimed to assess of efficacy of the kinesio taping with therapy on patients patients who diagnosed with globus pharyngeus.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Istanbul, Turkey, 34384
        • Prof Dr Cemil Tascioglu City Hospital
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Hasan Sami Bircan, MD
        • Sub-Investigator:
          • Yavuz Uyar, Prof., MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • diagnosed with globus pharyngeus
  • 18 -65 years
  • give a consent form

Exclusion Criteria:

  • patients with dysphagia or odynophagia
  • laryngeal organic pathologies
  • pharyngeal organic pathologies
  • epiglottic retroversion
  • malignancy
  • pregnancy
  • mental disorders
  • neurological disorders
  • major psychiatric disorders
  • give not a consent form

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Study group
The therapy and Kinesio tex gold tape that was affixed to stretched and neck localised were applied
The Kinesio tex tape is a medical tape that had been certified and patented.
Placebo Comparator: Sham control group
The therapy and Kinesio tex gold tape that was affixed to different neck localised as no-stretched were applied
The Kinesio tex tape is a medical tape that had been certified and patented.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The outcomes of Glasgow Edinburg Throat Scale
Time Frame: Baseline
It was assessed by Turkish validated Glasgow Edinburg Throat Scale that a self questionnaire in globus pharyngeus patients. The minimum score is 0 and maximum score is 7 per question. The high scores were worst low scores were good.
Baseline
The outcomes of Glasgow Edinburg Throat Scale
Time Frame: 4 weeks
It was assessed by Turkish validated Glasgow Edinburg Throat Scale that a self questionnaire in globus pharyngeus patients. The minimum score is 0 and maximum score is 7 per question. The high scores were worst low scores were good.
4 weeks
The outcomes of Glasgow Edinburg Throat Scale
Time Frame: 2 months
It was assessed by Turkish validated Glasgow Edinburg Throat Scale that a self questionnaire in globus pharyngeus patients. The minimum score is 0 and maximum score is 7 per question. The high scores were worst low scores were good.
2 months
The outcomes of Beck depression inventory
Time Frame: Baseline
It was assessed by Turkish validated depression inventory that a questionnaire about psychosocial situations. The minimum score is 0 and maximum score is 3 per question. The high scores were worst low scores were good.
Baseline
The outcomes of Beck depression inventory
Time Frame: 4 weeks
It was assessed by Turkish validated Beck depression inventory that a questionnaire about psychosocial situations. The minimum score is 0 and maximum score is 3 per question. The high scores were worst low scores were good.
4 weeks
The outcomes of Beck depression inventory
Time Frame: 2 months
It was assessed by Turkish validated Beck depression inventory that a questionnaire about psychosocial situations. The minimum score is 0 and maximum score is 3 per question. The high scores were worst low scores were good.
2 months
The outcomes of Beck anxiety inventory
Time Frame: Baseline
It was assessed by Turkish validated Beck anxiety inventory that a questionnaire about psychosocial situations. The minimum score is 0 and maximum score is 3 per question. The high scores were worst low scores were good.
Baseline
The outcomes of Beck anxiety inventory
Time Frame: 4 weeks
It was assessed by Turkish validated Beck anxiety inventory that a questionnaire about psychosocial situations. The minimum score is 0 and maximum score is 3 per question. The high scores were worst low scores were good.
4 weeks
The outcomes of Beck anxiety inventory
Time Frame: 2 months
It was assessed by Beck anxiety inventory that a questionnaire about psychosocial situations. The minimum score is 0 and maximum score is 3 per question. The high scores were worst low scores were good.
2 months
The visual analog scale
Time Frame: Baseline
The globus sense was assessed by visual analog scale. The minimum score is 0 and maximum score is 100 on a line as 100 millimetres . The high scores were worst low scores were good.
Baseline
The visual analog scale
Time Frame: 4 weeks
The globus sense was assessed by visual analog scale. The minimum score is 0 and maximum score is 100 on a line as 100 millimetres. The high scores were worst low scores were good.
4 weeks
The visual analog scale
Time Frame: 2 months
The globus sense was assessed by visual analog scale. The minimum score is 0 and maximum score is 100 on a line as 100 millimetres. The high scores were worst low scores were good.
2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Eating Assessment Tool
Time Frame: Baseline
The Turkish validated questionnaire consists of 10 questions that scores are from 0 to 40. Low score is better, higher score is worse.
Baseline
Eating Assessment Tool
Time Frame: 4 weeks
The Turkish validated questionnaire consists of 10 questions that scores are from 0 to 40. Low score is better, higher score is worse.
4 weeks
Eating Assessment Tool
Time Frame: 2 months
The Turkish validated questionnaire consists of 10 questions that scores are from 0 to 40. Low score is better, higher score is worse.
2 months
The outcomes of voice handicap index - 10
Time Frame: Baseline
It was assessed by Turkish validated voice handicap index - 10 that a self questionnaire in patients. The minimum score is 0 and maximum score is 4 per question. The high scores were worst low scores were good.
Baseline
The outcomes of voice handicap index - 10
Time Frame: 4 weeks
It was assessed by Turkish validated voice handicap index - 10 that a self questionnaire in patients. The minimum score is 0 and maximum score is 4 per question. The high scores were worst low scores were good.
4 weeks
The outcomes of voice handicap index - 10
Time Frame: 2 months
It was assessed by Turkish validated voice handicap index - 10 that a self questionnaire in patients. The minimum score is 0 and maximum score is 4 per question. The high scores were worst low scores were good.
2 months
The outcomes of reflux symptom index
Time Frame: Baseline
The laryngopharyngeal reflux was assessed by Turkish validated reflux symptom index - 10 that a self questionnaire in patients. The minimum score is 0 and maximum score is 5 per question. The high scores were worst low scores were good.
Baseline
The outcomes of reflux symptom index
Time Frame: 4 weeks
The laryngopharyngeal reflux was assessed by Turkish validated reflux symptom index - 10 that a self questionnaire in patients. The minimum score is 0 and maximum score is 5 per question. The high scores were worst low scores were good.
4 weeks
The outcomes of reflux symptom index
Time Frame: 2 months
The laryngopharyngeal reflux was assessed by Turkish validated reflux symptom index - 10 that a self questionnaire in patients. The minimum score is 0 and maximum score is 5 per question. The high scores were worst low scores were good.
2 months
Penetration and aspiration scale
Time Frame: Baseline
The scale consists of 8 levels for assessment of penetration and aspiration. The scores are from 0 to 8. Low score is better, higher score is worse.
Baseline
Yale pharyngeal residue severity rating scale
Time Frame: Baseline
The scale consists of 5 assessment units for pharyngeal residue. The scores are from 1 to 5. Low score is better, higher score is worse.
Baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subject demographics
Time Frame: Baseline
The median values of age and ratio of gender in all groups
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Yavuz Atar, Asso Prof,MD, University of Health Sciences, ENT Clinic, Prof Dr Cemil Tascioglu City Hospital
  • Study Director: Sevgi Atar, MD, University of Health Sciences, PMR Clinic, Prof Dr Cemil Tascioglu City Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 30, 2021

Primary Completion (Anticipated)

December 30, 2021

Study Completion (Anticipated)

December 30, 2021

Study Registration Dates

First Submitted

February 20, 2021

First Submitted That Met QC Criteria

February 20, 2021

First Posted (Actual)

February 24, 2021

Study Record Updates

Last Update Posted (Actual)

July 29, 2021

Last Update Submitted That Met QC Criteria

July 28, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Globus Pharyngeus

Clinical Trials on Kinesio tape

3
Subscribe